The COVID-19 pandemic has mainstreamed wastewater-based epidemiology, which analyzes sewage to detect disease outbreaks. Biobot Analytics can identify current community levels of disease and opioid use from just 150 ml of an aggregate sewage sample from a 24-hour period. Because samples include everyone in a sewage system, “there’s an incredible amount of intelligence in wastewater,” says Newsha Ghaeli, Biobot’s president and co-founder. The company is the first to commercialize data from sewage. The CDC in September expanded Biobot’s contract to include monkeypox monitoring.
More Must-Reads From TIME
- Alison Roman Won't Sugarcoat It
- If Donald Trump Is Indicted, Here's What Would Happen Next in the Process
- The World's Greatest Places of 2023
- Exclusive: Effective Altruist Leaders Were Repeatedly Warned About Sam Bankman-Fried Years Before FTX Collapsed
- Who Should Be on the 2023 TIME100? Vote Now
- Postmaster General Louis DeJoy's Surprising Second Act
- Gaslighting, Narcissist, and More Psychology Terms You're Misusing
- In This Texas County, There's No Such Thing as Moving on From COVID-19
- In Defense of Nora Ephron's Unfairly Panned Heartburn Movie
- Want Today's Top Headlines in Your Inbox? Sign Up for The Brief
